Source: European Medicines Agency (EU) Revision Year: 2022 Publisher: Takeda GmbH, Byk-Gulden-Str. 2, D-78467 Konstanz, Germany Telephone: 0800 825332 4 Telefax: 0800 825332 9
SOMAC Control 20 mg gastro-resistant tablets.
| Pharmaceutical Form |
|---|
|
Gastro-resistant tablet. Yellow, oval, biconvex film-coated tablets imprinted with “P20” in brown ink on one side. |
Each gastro-resistant tablet contains 20 mg pantoprazole (as sodium sesquihydrate).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Pantoprazole |
Pantoprazole is a substituted benzimidazole which inhibits the secretion of hydrochloric acid in the stomach by specific blockade of the proton pumps of the parietal cells. |
| List of Excipients |
|---|
|
Core: Sodium carbonate, anhydrous Coating: Hypromellose Printing ink: Shellac |
Alu/Alu blisters with or without cardboard reinforcement containing 7 or 14 gastro-resistant tablets
Not all pack sizes may be marketed.
Takeda GmbH, Byk-Gulden-Str. 2, D-78467 Konstanz, Germany
Telephone: 0800 825332 4
Telefax: 0800 825332 9
EU/1/09/516/001-004
Date of first authorisation: 12 June 2009
Date of latest renewal: 21 February 2014
| Drug | Countries | |
|---|---|---|
| SOMAC | Austria, Australia, Estonia, Finland, Croatia, Ireland, Italy, Lithuania, Poland |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
